For laboratory research only. Not for human consumption.Our comparison method ↗
Studio-style Deals on Peptides product visual for BPC-157 Atomized Solution Kit

Product comparison

BPC-157 Atomized Solution Kit prices

Compare BPC-157 Atomized Solution Kit listings by strength, selection and supplier. Inspect the original source behind each price.

1suppliers represented
2source-linked listings
0strengths available

MATCH SIZE AND QUANTITY

Build your comparison.

Daily snapshot · inspect sources

Choose a labeled amount and selection to load matching prices.

GO BEYOND THE PRICE

Track it. Plan it. Inspect it.

Select a strength and selection above to view price history, save a price watch or add it to your basket.

DOCUMENTATION PASSPORTS

Reports and batch records

Search all batch records

Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.

Loading documentation records…

Listed amounts and selections

Comparable quantities are not established for these source-defined selections. Inspect the original listing before comparing.

Reported quantities in this family: not established. Counts and units must be matched to the exact listing.

Compare the exact selection

Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.

Follow the original listing to check its quantity, availability and current price. 2 listings in this family have incomplete quantity details and receive no inferred per-mg price.

Suppliers with BPC-157 Atomized Solution Kit listings

1 profiles

Sources and comparison limits

2 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.

Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.

Explore more selection listings

Browse all products

FROM PEPTIDES CALCULATOR

About BPC-157

Source profile reviewed 2026-10-02 · Imported 2026-10-22. Read the full compound profile

BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide whose sequence was described by Predrag Sikiric's group at the University of Zagreb as a fragment of a protein found in human gastric juice. It has been studied almost entirely in rodent models of tendon, ligament, muscle, gut and vascular injury, where it is reported to speed healing. Human data are limited to three small pilot studies and one registered phase 1 safety trial that never posted results; it is not approved by any regulator, has been on the WADA prohibited list since 2022, and was placed in the FDA's Category 2 list of bulk substances that may present significant safety risks for compounding in 2023.

Formula
C62 H98 N16 O22
Molar mass
1,419.5 g/mol
CAS number
137525-51-0
Amino acids
15

Research evidence described in the source

Review

Orthopaedic sports-medicine systematic review

A 2025 systematic review of English-language literature identified predominantly preclinical musculoskeletal studies plus very limited human reporting, and noted the absence of strong clinical safety datasets.

Animal

Tendon and tendon-to-bone models

Rat Achilles-tendon and tendon-to-bone experiments report improved functional and structural healing markers versus controls in those models; results do not establish human efficacy.

In vitro

Tendon fibroblast outgrowth and migration

Cell and explant studies describe effects on tendon fibroblast outgrowth, survival under oxidative stress, and migration-related signaling pathways.

Human

Sparse clinical reporting

Human evidence remains sparse (small pilot / retrospective reports). No large randomized controlled trials establish clinical benefit or a settled safety profile.

Limitations noted in the source

  • Most positive findings come from animal or in-vitro models; translation to humans is unproven.
  • Published clinical data are few, small, and often uncontrolled.
  • Manufacturing quality, identity, and purity of research materials vary widely outside regulated drug development.
  • Optimal dose, route, duration, and long-term safety in humans are not established.
Publications and references linked by the source

Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.